Advertisement #1
HomeTagsImmunotherapy

Tag: immunotherapy

The History, Reality and Promise of Immunotherapy for Cancer

Daniel A. Vorobiof, MD-
Glioblastoma with extreme nuclear enlargement.

Dexamethasone Decreases the Efficacy of Immune Checkpoint Inhibitors in Patients With...

Editorial Team-

A New way of Identifying Tumor Response to Immunotherapy may Improve...

Editorial Team-
Featured Image: Research at Alkermes. Photo Courtesy: © 2020 Alkermes, Inc.

Re-Engineering Molecules to Drive Innovation in Cancer Immunotherapy

Heather Losey, Ph.D.-
Elias Sayour, MD, Ph.D., is the recipient of a U.S. $ 2.5 million grant from CureSearch For Children's Cancer. The award is to support a Phase I clinical trial of a novel RNA nanoparticle vaccine developed in his laboratory.

Researcher Embarks on First-in-human Clinical Trial of Novel Immunotherapy Vaccine for...

Peter Hofland, Ph.D-
Glioblastoma with extreme nuclear enlargement.

Cancer Vaccine Rindopepimut + Bevacizumab May Improve Outcomes in EGFRvIII+ Recurrent...

Peter Hofland, Ph.D-
Attendees and Speakers during Friday Scientific Workshop on Tumor Immune Interactions in Lymphoid Malignancies at the American Society of Hematology 60th Annual Meeting at the Orange County Convention Center on, Friday December 6, 2019. Photo courtesy © 2019 ASH/Matt Herp 2019

ASH 2019: Second-gen CAR T-Cell Therapy Overcome Resistance, Reduce Toxicity and...

Peter Hofland, Ph.D-

Enfortumab Vedotin + Pembrolizumab to be Evaluated in Metastatic Bladder Cancer

Peter Hofland, Ph.D-
SurVaxM. Photo Courtesy: 2019 Roswell Park.

Large Phase II Study to Investigate SurVaxM in Glioblastoma in China...

Peter Hofland, Ph.D-
Doctor discussing treatment options with a patient.

Erdafitinib, the First-Ever Targeted Therapy for Bladder Cancer, Receives Accelerated FDA...

Adil J. Akhtar, MD-
123Page 1 of 3

LATEST NEWS

Advertisment #12
© 2001 - 2020 Sunvalley Communication, LLC. All Rights Reserved.